Dehydroepiandrosterone in therapy of allergic diseases

Recent Patents on Inflammation and Allergy Drug Discovery

Volumn 3, Issue 3, 2009, Pages 211-213

  Kasperska Zajac, Alicja E ^a   Brzoza, Zenon K ^a   Koczy Baron, Ewa ^b   Jagodzinska, Julia ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Department of Dermatology and Venerology in Bytom ^*  (Poland)

Author keywords

Allergic diseases; Asthma; Dehydroepiandrosterone; Urticaria

Indexed keywords

PRASTERONE; PRASTERONE SULFATE; RESPIRATORY TRACT AGENT;

ALLERGIC DISEASE; ALLERGIC REACTION; ALLERGIC RHINITIS; ANTIINFLAMMATORY ACTIVITY; ASTHMA; ATOPIC DERMATITIS; ATOPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC URTICARIA; CLINICAL RESEARCH; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG POTENTIATION; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; IMMUNOREGULATION; INHALER; NONHUMAN; PATENT; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; TREATMENT RESPONSE; UNITED STATES;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; DEHYDROEPIANDROSTERONE; HUMANS; HYPERSENSITIVITY; PATENTS AS TOPIC; UNITED STATES;

EID: 70350749881     PISSN: 1872213X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221309789257360     Document Type: Review

References (51)

1. Bauliew EE, Robel P. Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids. Proc Natl Acad Sci USA 1998; 95(8): 4089-4091.
2. Dillon JS. Dehydroepiandrosterone, dehydroepiandrosterone sulfate and related steroids: Their role in inflammatory, allergic and immunological disorders. Curr Drug Targets Inflamm Allergy 2005; 4(3): 377-385.
3. Schwartz KE. Autoimmunity, dehydroepiandrosterone (DHEA), and stress. J Adolesc Health 2002; 30 (4 Suppl): S: 37-43.
4. Kroboth PD, Salek FS, Pittenger AL, Fabian TJ, Frye RF. DHEA and DHEA-S: A review. J Clin Pharmacol 1999; 39(4): 327-348.
5. Straub RH, Cutolo M. Involvement of the hypothalamic-pituitaryadrenal/ gonadal axis and the peripheral nervous system in rheumatoid arthritis: Viewpoint based on a systemic pathogenetic role. Arthritis Rheum 2001; 44(3): 493-507.
6. Barry NN, McGuire JL, van Vollenhoven RF. Dehydroepiandrosterone in systemic lupus erythematosus: Relationship between dosage, serum levels, and clinical response. J Rheumatol 1998; 25(12): 2352-2356.
7. Powell JM, Sonnenfeld G. The effects of dehydroepiandrosterone (DHEA) on in vitro spleen cell proliferation and cytokine production. J Interferon Cytokine Res 2006; 26(1): 34-39.
8. McLachlan JA, Serkin CD, Bakouche O. Dehydroepiandrosterone modulation of lipopolysaccharide-stimulated monocyte cytotoxicity. J Immunol 1996; 156(1): 328-335.
9. Yang NC, Jeng KC, Ho WM, Hu ML. ATP depletion is an important factor in DHEA-induced growth inhibition and apoptosis in BV-2 cells. Life Sci 2002; 70(17): 1979-1988.
10. Schulz S, Klann RC, Schonfeld S, Nyce JW. Mechanisms of cell growth inhibition and cell cycle arrest in human colonic adenocarcinoma cells by dehydroepiandrosterone: Role of isoprenoid biosynthesis. Cancer Res 1992; 52(5): 1372-1376.
11. Reed MJ. The discriminant-function test: A marker of Th1/Th2 cell cytokine secretion and breast tumour oestrogen synthesis. Mol Med Today 1995; 1(2): 98-103.
12. Tabata N, Tagami H, Terui T. Dehydroepiandrosterone may be one of the regulators of cytokine production in atopic dermatitis. Arch Dermatol Res 1997; 289(7): 410-414.
13. Sudo N, Yu XN, Kubo C. Dehydroepiandrosterone attenuates the spontaneous elevation of serum IgE level in NC/Nga mice. Immunol Lett 2001; 79(3): 177-179.
14. Yu CK, Yang BC, Lei HY, et al. Attenuation of house dust mite Dermatophagoides farinae-induced airway allergic responses in mice by dehydroepiandrosterone is correlated with down-regulation of TH2 response. Clin Exp Allergy 1999; 29(3): 414-422.
15. Tabata N, Tagami H, Terui T. Dehydroepiandrosterone may be one of the regulators of cytokine production in atopic dermatitis. Arch Dermatol Res 1997; 289(7): 410-404.
16. Dunn PJ, Mahood CB, Speed JF, Jury DR. Dehydroepiandrosterone sulphate concentrations in asthmatic patients: Pilot study. N Z Med J 1984; 97(768): 805-808.
17. Kos-Kudla B, Ostrowska Z, Marek B, et al. Circadian serum levels of dehydroepiandrosterone sulphate in postmenopausal asthmatic women before and after long-term hormone replacement. Endocr Regul 2001; 35(4): 217-222.
18. Kasperska-Zajac A, Brzoza Z, Rogala B. Serum concentration of dehydroepiandrosterone sulphate in female patients with chronic idiopathic urticaria. J Dermatol Sci 2006; 41(1): 80-81.
19. Kasperska-Zajac A, Brzoza Z, Rogala B. Lower serum concentration of dehydyroepiandrosterone sulphate in patients with chronic idiopathic urticaria. Allergy 2006; 61(12): 1489-1490.
20. Brzoza Z, Kasperska-Zajac A, Rogala B. Serum prolactin concentration and its relationship with dehydroepiandrosterone sulfate concentration in chronic urticaria patients with positive and negative response to autologous serum skin test. Allergy 2007; 62(5): 566-567.
21. Kasperska-Zajac A, Brzoza Z, Rogala B. Plasma concentration of interleukin 6 (IL-6), and its relationship with circulating concentration of dehydroepiandrosterone sulfate (DHEA-S) in patients with chronic idiopathic urticaria. Cytokine 2007; 39(2): 142-146.
22. Kasperska-Zajac A, Brzoza Z, Rogala B. Circulating concentration of dehydroepiandrosterone sulfate (DHEA-S) in women suffering from chronic idiopathic urticaria in relation to their pre- or postmenopausal status. Maturities 2007; 58(3): 211-215.
23. Kasperska-Zajac A, Brzoza Z, Rogala B. Dehydroepiandrosterone and dehydroepiandrosterone sulphate in atopic allergy and chronic urticaria. Inflammation 2008; 31(3): 141-145.
24. Brzoza Z, Kasperska-Zajac A, Badura-Brzoza K, Matysiakiewicz J, Hese RT, Rogala B. Decline in dehydroepiandrosterone sulphate observed in chronic urticaria is associated with psychological distress. Psychosom Med 2008; 70(6): 723-728.
25. Kasperska-Zajac A, Brzoza Z, Rogala B. Lower serum dehydroepiandrosterone sulfate (DHEA-S) concentration in chronic idiopathic urticaria: A secondary transient phenomenon? Br Dermatol J 2008; 159(3): 743-744.
26. Kasperska-Zajac A, Brzoza Z, Rogala B. Serum concentration of dehydroepiandrosterone sulfate and testosterone in female patients suffering from severe atopic/dermatitis syndrome (AEDS). J Invest Allergol Clin Immunol 2007; 17(3): 160-163.
27. Dowell, T., Norton, S.D., Araneo, B.A.: US5859000 (1999).
28. Pitchford SC, Page CP. Platelet activation in asthma: Integral to the inflammatory response. Clin Exp Allergy 2006; 36(4): 399-401.
29. Kasperska-Zajac A, Rogala B. Platelet activation during allergic inflammation. Inflammation 2007; 30(5): 161-166.
30. Kasperska-Zajac A, Rogala B. Platelet function in anaphylaxis. J Invest Allergol Clin Immunnol 2006; 16(1): 1-4.
31. Kasperska-Zajac A, Rogala B. Platelet activity measured by plasma levels of beta-thromboglobulin and platelet factor 4 in seasonal allergic rhinitis during natural pollen exposure. Inflamm Res 2003; 52(11): 477-479.
32. Kasperska-Zajac A, Rogala B. Markers of platelet activation in plasma of patients suffering from persistent allergic rhinitis with or without asthma symptoms. Clin Exp Allergy 35(11): 1462-1465.
33. Kasperska-Zajac A, Brzoza Z, Rogala B. Effect of allergen-specific immunotherapy on plasma level of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG), platelet activation markers in patients with house-dust mite allergy. Vaccine 2007; 25(18): 3595-3598.
34. Kasperska-Zajac A, Brzoza Z, Rogala B. Effect of allergen-specific immunotherapy on platelet secretory activity in patients with grasspollen allergy. Vaccine 2006; 24(47-48): 6990-6993.
35. Kasperska-Zajac A, Rogala B, Nowakowski M. Assessment of platelet activity, expressed by plasma levels of platelet factor 4 and beta-thromboglobulin in patients with chronic idiopathic urticaria. Exp Dermatol 2005; 14(7): 515-518.
36. Kasperska-Zajac A, Brzoza Z, Rogala B. Circulating level of the platelet-derived CXC chemokine platelet factor 4 in chronic urticaria patients with or without coexistent euthyroid Hashimoto's thyroiditis. Autoimmunity 2006; 39(4): 265-268.
37. Kasperska-Zajac A, Brzoza Z, Rogala B. Increased secretion of platelet specific chemokines in patients with delayed pressure urticaria. Eur Cytokine Netw 2008; 19(2): 89-91.
38. Kasperska-Zajac A, Rogala B. Behaviour of indexes of platelet activity and active fibrinolysis in plasma from patients with seasonal allergic rhinitis and concomitant asthma during pollen season. Adv Clin Exp Med 2006; 15(3): 23-28.
39. Kasperska-Zajac A, Brzoza Z, Rogala B. Seasonal changes in platelet activity in patients with pollen-induced seasonal allergic rhinitis and seasonal asthma. J Asthma 2008; 45(6): 485-487.
40. Kasperska-Zajac A, Nowakowski M, Rogala B. Enhanced platelet activation in patients with atopic eczema/dermatitis syndrome. Inflammation 2004; 28(5): 299-302.
41. Kasperska-Zajac A, Brzoza Z, Rogala B. Platelet function in cutaenous diseases. Platelets 2008; 19(5): 317-321.
42. Leonard, S.A., Johnson, K.A.: US20040067920 (2004).
43. Robinson, C.B., Ball, H.A.: US20050085428 (2005).
44. Robinson, C.B., Ball, H.A.: US20050227927 (2005).
45. Robinson, C.B., Ball, H.A.: US20050222049 (2005).
46. Robinson, C.B., Ball, H.A.: US20050261208 (2005).
47. Robinson, C.B., Ball, H.A.: US20050101544 (2005).
48. Robinson, C.B., Ball, H.A.: US20050026890 (2005).
49. Robinson, C.B., Ball, H.A.: US20050113318 (2005).
50. Robinson, C.B., Ball, H.A.: US20050101545 (2005).
51. Robinson, C.B., Ball, H.A.: US20050113317 (2005).